Brief: Rosetta Genomics and Marina Biotech start first clinical project under strategic alliance
18/11/2014 13:00
Nov 18 (Reuters) - Rosetta Genomics Ltd ROSG.O : * Press release - Rosetta Genomics and marina biotech initiate first clinical project under strategic alliance * 1st project to be clinical study conducted by co to identify novel microrna candidates for treatment of duchenne muscular dystrophy * In clinical study, Rosetta will evaluate archived muscle biopsy samples from 10-30 dmd patients and 10-30 non-dmd controls * Source text for Eikon ID:nMKWdVl1Ta * Further company coverage ROSG.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics